Sarasota's Roskamp Institute Discovers New Class Of Drugs That Can Impact Alzheimer's Disease
Fri, 26 Jan 2007 08:00 AM EST
... The Roskamp Institute announced today the discovery of a new class of drugs that lower the production of the main pathological protein that causes Alzheimer's disease. The discovery is detailed in an article co-authored by Drs. Daniel Paris and Michael Mullan and currently appears in Neuroscience Letters. [click link for full article] ...
Related Topics
- Alzheimer's Disease
- Alzheimer's Caregivers
- Coronary Artery Disease
- Coronary Artery Diseases
- Infectious Diseases
- Alzheimer disease
- Lamaze
- Disease-modifying anti-rheumatoid drugs
- Celecoxib
- Diseases & Conditions
- Heart Disease
- Bone Disease
- Lung Diseases & Disorders
- Huntington's Disease
- Kidney Disease
- Rare Diseases
- Crohn's Disease
- Graves' Disease
- Autoimmune Diseases
- Periodontal Disease

Not Signed In -

